RND-001

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameRND-001
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone deacetylase inhibitors
TargetsHistone deacetylase
Therapy Area/IndicationsLysosomal Storage DiseasesNeurodegenerative Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRaNeDis Pharmaceuticals LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAmo PharmaRaNeDis Pharmaceuticals LLC
Active IndicationsN/A
Inactive IndicationsLysosomal Storage DiseasesNeurodegenerative Diseases

Other Information

ATC CodeN/A
Related LinksN/A